These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38814439)
1. Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients. Hodan R; Picus M; Stanclift C; Ormond KE; Pichardo JM; Kurian AW; Ricker C; Idos GE J Community Genet; 2024 Aug; 15(4):363-374. PubMed ID: 38814439 [TBL] [Abstract][Full Text] [Related]
2. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Culver JO; Ricker CN; Bonner J; Kidd J; Sturgeon D; Hodan R; Kingham K; Lowstuter K; Chun NM; Lebensohn AP; Rowe-Teeter C; Levonian P; Partynski K; Lara-Otero K; Hong C; Morales Pichardo J; Mills MA; Brown K; Lerman C; Ladabaum U; McDonnell KJ; Ford JM; Gruber SB; Kurian AW; Idos GE Cancer; 2021 Apr; 127(8):1275-1285. PubMed ID: 33320347 [TBL] [Abstract][Full Text] [Related]
3. Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. Idos GE; Kurian AW; Ricker C; Sturgeon D; Culver JO; Kingham KE; Koff R; Chun NM; Rowe-Teeter C; Lebensohn AP; Levonian P; Lowstuter K; Partynski K; Hong C; Mills MA; Petrovchich I; Ma CS; Hartman AR; Allen B; Wenstrup RJ; Lancaster JM; Brown K; Kidd J; Evans B; Mukherjee B; McDonnell KJ; Ladabaum U; Ford JM; Gruber SB JCO Precis Oncol; 2019 Mar; 3():. PubMed ID: 34322651 [TBL] [Abstract][Full Text] [Related]
4. Exploring relatives' perceptions of participation, ethics, and communication in a patient-driven study for hereditary cancer variant reclassification. Tsai GJ; Chen AT; Garrett LT; Burke W; Bowen DJ; Shirts BH J Genet Couns; 2020 Oct; 29(5):857-866. PubMed ID: 31916645 [TBL] [Abstract][Full Text] [Related]
5. Patient communication of cancer genetic test results in a diverse population. Ricker CN; Koff RB; Qu C; Culver J; Sturgeon D; Kingham KE; Lowstuter K; Chun NM; Rowe-Teeter C; Lebensohn A; Levonian P; Partynski K; Lara-Otero K; Hong C; Petrovchich IM; Mills MA; Hartman AR; Allen B; Ladabaum U; McDonnell K; Ford JM; Gruber SB; Kurian AW; Idos GE Transl Behav Med; 2018 Jan; 8(1):85-94. PubMed ID: 29385580 [TBL] [Abstract][Full Text] [Related]
6. A content analysis of parents' reflections on pathogenic and uncertain pediatric oncology germline sequencing results. Howard Sharp KM; Clark ME; Jurbergs N; Ouma A; Harrison L; Taylor L; Hamilton K; McGee RB; Nuccio R; Hines-Dowell S; Gattuso JS; Pritchard M; Mandrell B; Tercyak KP; Johnson LM; Nichols KE Fam Cancer; 2024 Nov; 23(4):551-561. PubMed ID: 39302531 [TBL] [Abstract][Full Text] [Related]
7. Cancer patients' understandings of genetic variants of uncertain significance in clinical care. Amano Y; Raz A; Timmermans S; Shkedi-Rafid S J Community Genet; 2022 Aug; 13(4):381-388. PubMed ID: 35616809 [TBL] [Abstract][Full Text] [Related]
8. A Modern Dilemma: How Experts Grapple with Ambiguous Genetic Test Results. Scherr CL; Ross Arguedas AA; Getachew-Smith H; Marshall-Fricker C; Shrestha N; Brooks K; Fischhoff B; Vadaparampil ST Med Decis Making; 2020 Jul; 40(5):655-668. PubMed ID: 32734842 [No Abstract] [Full Text] [Related]
9. The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer. Conley CC; Ketcher D; Reblin M; Kasting ML; Cragun D; Kim J; Ashing KT; Knott CL; Hughes-Halbert C; Pal T; Vadaparampil ST J Genet Couns; 2020 Jun; 29(3):410-422. PubMed ID: 31912597 [TBL] [Abstract][Full Text] [Related]
10. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019. Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870 [TBL] [Abstract][Full Text] [Related]
11. Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer. Ro V; McGuinness JE; Guo B; Trivedi MS; Jones T; Chung WK; Rao R; Levinson E; Koval C; Russo D; Chilton I; Kukafka R; Crew KD JCO Oncol Pract; 2022 Apr; 18(4):e472-e483. PubMed ID: 34705516 [TBL] [Abstract][Full Text] [Related]
12. Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants. Liu YL; Maio A; Kemel Y; Salo-Mullen EE; Sheehan M; Tejada PR; Trottier M; Arnold AG; Fleischut MH; Latham A; Carlo MI; Murciano-Goroff YR; Walsh MF; Mandelker D; Mehta N; Bandlamudi C; Arora K; Zehir A; Berger MF; Solit DB; Aghajanian C; Diaz LA; Robson ME; Brown CL; Offit K; Hamilton JG; Stadler ZK Cancer; 2022 Nov; 128(21):3870-3879. PubMed ID: 36041233 [TBL] [Abstract][Full Text] [Related]
13. Most people share genetic test results with relatives even if the findings are normal: Family communication in a diverse population. Hunter JE; Riddle L; Joseph G; Amendola LM; Gilmore MJ; Zepp JM; Shuster E; Bulkley JE; Muessig KR; Anderson KP; Goddard KAB; Wilfond BS; Leo MC; Genet Med; 2023 Nov; 25(11):100923. PubMed ID: 37421176 [TBL] [Abstract][Full Text] [Related]
14. Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics. Menke C; Nagaraj CB; Dawson B; He H; Tawde S; Wakefield EG J Genet Couns; 2021 Dec; 30(6):1559-1569. PubMed ID: 33969574 [TBL] [Abstract][Full Text] [Related]
15. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients. Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778 [TBL] [Abstract][Full Text] [Related]
16. Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. Abdel-Razeq H; Abujamous L; Al-Azzam K; Abu-Fares H; Bani Hani H; Alkyam M; Sharaf B; Elemian S; Tamimi F; Abuhijla F; Edaily S; Salama O; Abdulelah H; Daoud R; Abubaker M; Al-Atary A Breast Cancer (Dove Med Press); 2023; 15():1-10. PubMed ID: 36660366 [TBL] [Abstract][Full Text] [Related]
17. Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes. Miller IM; Lewis KL; Lawal TA; Ng D; Johnston JJ; Biesecker BB; Biesecker LG Genet Med; 2019 Mar; 21(3):748-752. PubMed ID: 29997389 [TBL] [Abstract][Full Text] [Related]
18. Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program. Jones JC; Golafshar MA; Coston TW; Rao R; Wysokinska E; Johnson E; Esplin ED; Nussbaum RL; Heald B; Klint M; Barrus K; Uson PL; Nguyen CC; Colon-Otero G; Bekaii-Saab TS; Dronca R; Kunze KL; Samadder NJ Cureus; 2023 Apr; 15(4):e37428. PubMed ID: 37181954 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data. van Marcke C; Collard A; Vikkula M; Duhoux FP Crit Rev Oncol Hematol; 2018 Dec; 132():138-144. PubMed ID: 30447919 [TBL] [Abstract][Full Text] [Related]
20. Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer. Gunawardena K; Sirisena ND; Anandagoda G; Neththikumara N; Dissanayake VHW BMC Res Notes; 2023 Jun; 16(1):95. PubMed ID: 37277882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]